FDA Adds New Side Effect Warnings to Ozempic A study out of China published in May 2023 found that GLP-1 drugs might cause the intestines to lengthen and become inelastic, which may increase the risk of a blockage
Obesity and overweight fact sheet
Activation of nuclear factor-B (NF-B) induces transcription of target genes that primarily encode survival proteins (e.g., cellular FLICE-like inhibitory protein and inhibitor of apoptosis proteins) via formation of the complex I signalosome after binding to TNF receptor-1
Be vigilant for symptoms such as: Muscle weakness or cramps Irregular heartbeat or chest discomfort Difficulty breathing or confusion Yellowing of the skin or eyes Severe rashes or blistering on the skin If you experience any of these warning signs - or persistent issues like nausea, vomiting, stomach pain, or extreme dizziness - reach out to your healthcare provider immediately
DIO mice received 1, 5, 10 or 25 g per l per mouse of mGIPR-Ab/P3 or 25 g per l per mouse of IgG1 control injected ICV every 4 days for five treatments, with body weight and food intake monitored for 44 days
While GLP-1 agonists can be valuable tools in your arsenal, theyre most effective when paired with meaningful lifestyle changes and a clear plan for the future